Scholars Central

Case reportPublished 24 Oct 2014

Submucosal Lipiodol Injection to Guide Radiotherapy for Esophageal Cancer

Authors: Han Yao, Christian Boukaram, George Rakovich

Journal of Gastrointestinal & Digestive System

Volume 4 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Radiotherapy for esophageal cancer relies on cross-sectional imaging to identify the entire extent of tumor. Rarely, the exact limits of the tumor may be radiologically occult. Lipiodol is a contrast agent which has been used successfully to mark cancers of the bladder and lung for radiotherapy and surgical resection. We report a patient with an adenocarcinoma of the gastroesophageal junction with tiny tumor implants extending proximally along the length of the esophagus, which were not visible on standard cross-sectional imaging studies. The proximal extent of implants was marked endoscopically using a submucosal injection of lipiodol, and this provided for adequate planning and successful delivery of radiotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Gastrointestinal & Digestive System.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Gastrointestinal & Digestive System
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Han Yao”
  • BylineArticles whose byline prints “Christian Boukaram”
  • BylineArticles whose byline prints “George Rakovich”